Polymorphisms in telomere maintenance genes and risk of lung cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 10, 2009, Pages 2773-2781

  Jin, Eun Choi ^a   Kang, Hyo Gyoung ^b   Jin, Sung Jang ^a   Yi, Young Choi ^a   Min, Jung Kim ^a   Jong, Sik Kim ^a   Jeon, Hyo Sung ^a,b   Won, Kee Lee ^a   Sung, Ick Cha ^b   Chang, Ho Kim ^b   Sin, Kam ^a   Tae, Hoon Jung ^b   Jae, Yong Park ^a,b  

^a Kyungpook National University School of Medicine   (South Korea)

^b Kyungpook National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

POT1 PROTEIN; RAP1 PROTEIN; RIBONUCLEOPROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; TELOMERIC REPEAT BINDING FACTOR 1; TELOMERIC REPEAT BINDING FACTOR 2; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SOUTH KOREA; STATISTICAL SIGNIFICANCE; TELOMERE;

AGED; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING; TELOMERASE; TELOMERE;

EID: 70350120461     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0323     Document Type: Article

References (40)

1. Blasco MA. Telomeres and human disease: aging, cancer and beyond. Nat Rev Genet 2005;6:611-622 (Pubitemid 41044298)
2. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 2005;19:2100-2110
3. Liu D, O'Connor MS, Qin J, Songyang Z. Telosome, a mammalian telomere- associated complex formed by multiple telomeric proteins. J Biol Chem 2004;279:51338-51342 (Pubitemid 40017880)
4. Chan SW, Blackburn EH. New ways not to make ends meet: telomerase, DNA damage proteins and heterochromatin. Oncogene 2002;21: 553-563
5. Collins K, Mitchell JR. Telomerase in the human organism. Oncogene 2002;21:564-579
6. Smogorzewska A, de Lange T. Regulation of telomerase by telomeric proteins. Annu Rev Biochem 2004;73:177-208.
7. Kim SH, Kaminker P, Campisi J. TIN2, a new regulator of telomere length in human cells. Nat Genet 1999;23:405-412
8. Smith S, Giriat I, Schmitt A, de Lange T. Tankylase, a poly(ADPribose) polymerase at human telomeres. Science 1998;282:1484-1487 (Pubitemid 28538609)
9. van Steensel B, Smogorzewska A, de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell 1988;92:401-413
10. O'Connor MS, Safari A, Liu D, et al. The human Rap1 protein complex and modulation of telomere length. J Biol Chem 2004;279:28585-28591 (Pubitemid 38900141)
11. Lyayza D, de Lange T. POT1 as a terminal transducer of TRF1 telomere length control. Nature 2003;423:1013-1018
12. Hastie ND, Dempster M, Dunlop MG, et al. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990;346: 866-868 (Pubitemid 20272111)
13. Iwama H, Ohyashiki K, Ohyashiki JH, et al. Telomere length and telomerase activity with age in peripheral blood cells obtained from normal individuals. Hum Genet 1998;102:397-402. (Pubitemid 28203979)
14. Flenck RW, Blackburn EH, Shannon KM. The rate of telomere sequence loss in human leukocytes varies with age. Proc Natl Acad Sci U S A 1998;95:5607-5610
15. Valdes AM, Andrew T, Gardner JP, et al. Obesity, cigarette smoking, and telomere length in women. Lancet 2005;366:662-664 (Pubitemid 41176019)
16. von Zglinicki T. Role of oxidative stress in telomere length regulation and replicative senescence. Ann N Y Acad Sci 2000;908:99-110. (Pubitemid 30461996)
17. Wu X, Amos CI, Zhu Y, et al. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst 2003;95:1211-1218 (Pubitemid 37069551)
18. McGrath M, Wong JYY, Michaud D, et al. Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers Prev 2007;16:815-819 (Pubitemid 46650587)
19. Jang JS, Choi YY, Lee WK, et al. Telomere length and the risk of lung cancer. Cancer Sci 2008;99:1385-1389 (Pubitemid 351761728)
20. Lee SJ, Jeon HS, Jang JS, et al. DNMT3B polymorphisms and risk of primary lung cancer. Carcinogenesis 2005;26:403-409 (Pubitemid 40246562)
21. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-2229 (Pubitemid 34680308)
22. Stephens M, Smith MJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68: 978-989 (Pubitemid 32289743)
23. Hsu CP, Hsu NY, Lee LW, Ko JL. Ets2 binding site single nucleotide polymorphism at the hTERT gene promoter-effect on telomerase expression and telomere maintenance in non-small cell lung cancer. Eur J Cancer 2006;42:1466-1474
24. Ducrest AL, Szutorisz H, Linger J, Nabholz M. Regulation of the human telomerase reverse transcriptase gene. Oncogene 2002;21: 541-552 (Pubitemid 34146254)
25. Kyo S, Inoue M. Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can apply them for cancer therapy? Oncogene 2002;21:688-697
26. Takakura M, Kyo S, Kanaya T, et al. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res 1999;59:551-557 (Pubitemid 29076049)
27. HorikawaI, Cable PL, Afshari C, Barrett JC. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res 1999;59:826. (Pubitemid 30035625)
28. Matsubara Y, Murata M, Yoshida T, et al. Telomere length of normal leukocytes is affected by a functional polymorphism of hTERT. Biochem Biophys Res Commun 2006;341:128-131 (Pubitemid 43117395)
29. Savage SA, Chanock SJ, Lissowska J, et al. Genetic variation in five genes important in telomere biology and risk for breast cancer. Br J Cancer 2007;97:832-836 (Pubitemid 47396285)
30. Brennan P. Gene-environment interaction and aetiology of cancer: what does it mean and how can we measure it? Carcinogenesis 2002;23:381-387
31. Varadi V, Brendle A, Grzybowska E, et al. A functional promoter polymorphism in the TERT gene does not affect inherited susceptibility to breast cancer. Cancer Genet Cytogenet 2009;190:71-74
32. Lin PI, Vance JM, Pericak-Vance MA, Martin ER. No gene is an island: the flip-flop phenomenon. Am J Hum Genet 2007;80:531-538
33. Chin L, Artandi SE, Shen Q, et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 1999;97:527-538 (Pubitemid 29231175)
34. Artandi SE, Chang S, Lee SL, et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 2000;406:641-645 (Pubitemid 30641052)
35. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clue to cancer etiology and molecular pathogenesis. Cancer Res 1994;54:4855-4878 (Pubitemid 24289415)
36. Yim HW, Slebos RJC, Randell SH, et al. Smoking is associated with increased telomerase activity in short-term cultures of human bronchial epithelial cells. Cancer Lett 2007;246:24-33.
37. Hung RJ, McKay JD, Gaborieau V, et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008;452:633-637
38. Amos CI, Wu X, Broderick P, et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 2008;40:616-622 (Pubitemid 351601203)
39. McKay J, Hung RJ, Gaborieau V, et al. Lung cancer susceptibility locus at 5p15.33. Nat Genet 2008;40:1404-1406
40. Mushiroda T, Wattanapokayakit S, Takahashi A, et al. A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis. J Med Genet 2008;45:654-656